Mesenchymal Stem Cells Expressing Vasoactive Intestinal Peptide Ameliorate Symptoms in a Model of Chronic Multiple Sclerosis
Multiple sclerosis (MS) is a severe debilitating disorder characterized by progressive demyelination and axonal damage of the central nervous system (CNS). Current therapies for MS inhibit the immune response and demonstrate reasonable benefits if applied during the early phase of relapsing–remittin...
Main Authors: | Marién Cobo, Per Anderson, Karim Benabdellah, Miguel G. Toscano, Pilar Muñoz, Angélica García-Pérez, Iván Gutierrez, Mario Delgado, Francisco Martin |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2013-05-01
|
Series: | Cell Transplantation |
Online Access: | https://doi.org/10.3727/096368912X657404 |
Similar Items
-
Vasoactive Intestinal Peptide : Control of Hippocampal Neurogenesis
by: Zaben, Malik J.
Published: (2007) -
Vasoactive intestinal peptide producing pheochromocytoma and intracardiac thrombosis
by: Melody Hermel, et al.
Published: (2021-04-01) -
Role of vasoactive intestinal peptide in Aspergillus fumigatus-infected cornea
by: Cui Li, et al.
Published: (2018-02-01) -
Select cognitive deficits in Vasoactive Intestinal Peptide deficient mice
by: Hagopian Arkady, et al.
Published: (2008-07-01) -
Biological and chemical characterisation of novel forms of vasoactive intestinal peptide
by: Thwaites, David Thomas
Published: (1989)